Nerandomilast bulk supplier for pharma manufacturers

Nerandomilast Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg

Reference Brands: Jascayd (USA/EU)

Category: Respiratory Disorder

Nerandomilast is a selective phosphodiesterase-4B inhibitor used in the management of moderate to severe chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the airways and improving lung function. It is taken orally once daily and designed to have fewer gastrointestinal side effects than earlier PDE-4 inhibitors. Nerandomilast is available in Tablets and strengths such as 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Nerandomilast is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Nerandomilast can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Nerandomilast is used for the treatment of idiopathic pulmonary fibrosis (IPF). It helps slow the decline in lung function and manages disease progression.

It is made from the active molecule nerandomilast (also known as BI-1015550), a preferential phosphodiesterase-4B (PDE4B) inhibitor.

The trade name is Jascayd.

It is developed and manufactured by Boehringer Ingelheim.

The generic name is Nerandomilast.

The brand name is Jascayd.

It is manufactured by Boehringer Ingelheim in its global production facilities, with distribution in approved international markets.

Yes, Nerandomilast is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Nerandomilast is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Levalbuterol

Strength:
0.31 mg, 0.63 mg, 1.25 mg

Form: Inhalation solution

Reference Brands: Xopenex (USA/EU)

View Details
Umeclidinium Bromide

Strength:
62.5 mcg

Form: dry-powder inhaler

Reference Brands: Incruse Ellipta (USA)

View Details
Benralizumab

Strength:
30 mg/mL

Form: Injection

Reference Brands: Fasenra (USA/EU)

View Details
Mannitol

Strength:
40mg

Form: inhalation powder capsules

Reference Brands: Bronchitol (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.